Hien Thi Tran

Array ( [id] => 6544597 [patent_doc_number] => 20020137678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Treatment of ocular neovascularization and related diseases' [patent_app_type] => new [patent_app_number] => 09/836503 [patent_app_country] => US [patent_app_date] => 2001-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11912 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137678.pdf [firstpage_image] =>[orig_patent_app_number] => 09836503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 408332 [patent_doc_number] => 07285649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-23 [patent_title] => 'Isolated nucleic acids, vectors and host cells encoding ErbB3 antibodies' [patent_app_type] => utility [patent_app_number] => 09/825584 [patent_app_country] => US [patent_app_date] => 2001-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 19604 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/285/07285649.pdf [firstpage_image] =>[orig_patent_app_number] => 09825584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 386542 [patent_doc_number] => 07303911 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-04 [patent_title] => 'Prostate cell lines' [patent_app_type] => utility [patent_app_number] => 10/240523 [patent_app_country] => US [patent_app_date] => 2001-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 5628 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/303/07303911.pdf [firstpage_image] =>[orig_patent_app_number] => 10240523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6157681 [patent_doc_number] => 20020146750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Mucin-1 specific binding members and methods of use thereof' [patent_app_type] => new [patent_app_number] => 09/822698 [patent_app_country] => US [patent_app_date] => 2001-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 32520 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 41 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146750.pdf [firstpage_image] =>[orig_patent_app_number] => 09822698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1132540 [patent_doc_number] => 06783760 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-31 [patent_title] => 'Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids' [patent_app_type] => B1 [patent_app_number] => 09/819386 [patent_app_country] => US [patent_app_date] => 2001-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 72758 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/783/06783760.pdf [firstpage_image] =>[orig_patent_app_number] => 09819386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5827924 [patent_doc_number] => 20020068043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Bi-functional cancer treatment agents' [patent_app_type] => new [patent_app_number] => 09/815306 [patent_app_country] => US [patent_app_date] => 2001-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10852 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068043.pdf [firstpage_image] =>[orig_patent_app_number] => 09815306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6814063 [patent_doc_number] => 20030073613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Angiogenisis associated proteins, and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 09/815379 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50000 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073613.pdf [firstpage_image] =>[orig_patent_app_number] => 09815379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062889 [patent_doc_number] => 20020031506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Human glutathione peroxidase-6' [patent_app_type] => new [patent_app_number] => 09/811118 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21273 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20020031506.pdf [firstpage_image] =>[orig_patent_app_number] => 09811118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174493 [patent_doc_number] => 20020155115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Novel proteins and nucleic acids encoding same' [patent_app_type] => new [patent_app_number] => 09/808602 [patent_app_country] => US [patent_app_date] => 2001-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68915 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155115.pdf [firstpage_image] =>[orig_patent_app_number] => 09808602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1062895 [patent_doc_number] => 06849599 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-01 [patent_title] => 'Combination drug therapy' [patent_app_type] => utility [patent_app_number] => 09/802094 [patent_app_country] => US [patent_app_date] => 2001-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1974 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/849/06849599.pdf [firstpage_image] =>[orig_patent_app_number] => 09802094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5801473 [patent_doc_number] => 20020009757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'Screening assays for agents that alter inhibitor of apoptosis (IAP) protein regulation of caspase activity' [patent_app_type] => new [patent_app_number] => 09/799994 [patent_app_country] => US [patent_app_date] => 2001-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18943 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20020009757.pdf [firstpage_image] =>[orig_patent_app_number] => 09799994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545733 [patent_doc_number] => 20020110851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'Novel polypeptides, modulatory agents therefor and methods of using them' [patent_app_type] => new [patent_app_number] => 09/798116 [patent_app_country] => US [patent_app_date] => 2001-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 30342 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20020110851.pdf [firstpage_image] =>[orig_patent_app_number] => 09798116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6544567 [patent_doc_number] => 20020137676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Selective treatment of endothelial somatostatin receptors' [patent_app_type] => new [patent_app_number] => 09/797779 [patent_app_country] => US [patent_app_date] => 2001-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8637 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137676.pdf [firstpage_image] =>[orig_patent_app_number] => 09797779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 626794 [patent_doc_number] => 07135177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-14 [patent_title] => 'Immunoliposomes that optimize internalization into target cells' [patent_app_type] => utility [patent_app_number] => 09/797544 [patent_app_country] => US [patent_app_date] => 2001-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 14005 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/135/07135177.pdf [firstpage_image] =>[orig_patent_app_number] => 09797544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 840306 [patent_doc_number] => 07390634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-24 [patent_title] => 'β-netrin and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/795671 [patent_app_country] => US [patent_app_date] => 2001-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 49837 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/390/07390634.pdf [firstpage_image] =>[orig_patent_app_number] => 09795671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1188782 [patent_doc_number] => 06734013 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-11 [patent_title] => 'Use of multivalent chimeric peptide-loaded, MHC/Ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses' [patent_app_type] => B2 [patent_app_number] => 09/789720 [patent_app_country] => US [patent_app_date] => 2001-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 29 [patent_no_of_words] => 14116 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/734/06734013.pdf [firstpage_image] =>[orig_patent_app_number] => 09789720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6409779 [patent_doc_number] => 20020038012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Novel human regulatory protein and polynucleotides encoding the same' [patent_app_type] => new [patent_app_number] => 09/790318 [patent_app_country] => US [patent_app_date] => 2001-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7895 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20020038012.pdf [firstpage_image] =>[orig_patent_app_number] => 09790318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6291370 [patent_doc_number] => 20020055456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Therapeutic methods that target fractalkine or CX3CR1' [patent_app_type] => new [patent_app_number] => 09/789486 [patent_app_country] => US [patent_app_date] => 2001-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22778 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055456.pdf [firstpage_image] =>[orig_patent_app_number] => 09789486 [rel_patent_id] =>[rel_patent_doc_number] =>)